Abstract: Severe equine asthma (sEA) is characterized by increased lower airway neutrophils that contribute to dysregulated inflammation through the release of cytokines, reactive oxygen species and neutrophil extracellular traps (NETs). NETs are composed of cell-free DNA (cfDNA) intercalated with enzymatic proteins and are known to be increased in the lower airway of asthmatic horses. The objectives of this study were two-fold: 1. Determine if cfDNA can be accurately measured in equine bronchoalveolar lavage fluid (BALF) and tracheal wash (TW) with a Qubit 4 fluorometer. 2. Determine whether Qubit-measured cfDNA in BALF or TW is significantly different in horses with sEA, mild/moderate neutrophilic equine asthma, mastocytic equine asthma and healthy horses. A total of sixty-three horses received a physical examination and clinical score followed by a BAL +/- TW. Cell-free DNA was measured using three methods in unfiltered BAL and TW as well as BAL and TW supernatant. Cell-free DNA concentrations were highly correlated between the Qubit 4 fluorometer and NanoDrop spectrophotometer as well as between the Qubit 4 fluorometer and SYTOX green plate-based assay. Cell-free DNA concentrations were highly correlated between unfiltered TW and TW supernatant as well as between unfiltered BALF and BAL supernatant. Cell-free DNA concentrations in BAL and TW supernatant were significantly higher in horses with sEA compared to healthy horses or horses with mild/moderate equine asthma. Cell-free DNA is a biomarker of sEA that can be easily measured in the field with the small portable Qubit 4 fluorometer in BAL and TW fluid. These findings support further investigation of NETs as a biomarker and potential therapeutic target for severe equine asthma.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study investigated whether a portable device called the Qubit 4 fluorometer can accurately measure cell-free DNA (cfDNA) in airway fluid samples from horses.
It found that horses with severe equine asthma have significantly higher levels of cfDNA in their airway fluids compared to healthy horses or those with milder asthma.
Background
Severe Equine Asthma (sEA): A chronic respiratory disease in horses characterized by increased neutrophils— a type of immune cell—in the lower airways.
Neutrophil Extracellular Traps (NETs): Structures composed mainly of cell-free DNA combined with enzymatic proteins released by neutrophils during inflammation.
Importance of NETs: They contribute to the dysregulated inflammation seen in sEA and their levels are elevated in affected horses, making them promising markers for disease severity.
Study Objectives
To assess whether cfDNA can be accurately quantified in bronchoalveolar lavage fluid (BALF) and tracheal wash (TW) samples from horses using the Qubit 4 fluorometer.
To determine if cfDNA levels measured by Qubit 4 differ significantly among horses with severe equine asthma, mild/moderate neutrophilic or mastocytic equine asthma, and healthy controls.
Methods
Subjects: Sixty-three horses undergoing physical examination and clinical scoring.
Three different methods were used to measure cfDNA: Qubit 4 fluorometer, NanoDrop spectrophotometer, and SYTOX green plate-based assay.
Measurements taken from both unfiltered samples and supernatants (fluid after centrifugation) of BAL and TW.
Key Findings
cfDNA concentrations measured by Qubit 4 showed strong correlation with measurements from NanoDrop spectrophotometer and SYTOX green assay, affirming the accuracy of the Qubit 4.
cfDNA levels were highly correlated between unfiltered and supernatant samples, indicating cfDNA is accessible in both sample types.
Horses with severe equine asthma had significantly elevated cfDNA levels in both BAL and TW supernatant compared to healthy horses and those with mild/moderate asthma.
Implications
The Qubit 4 fluorometer, a small and portable device, can reliably measure cfDNA in airway samples, making it practical for field use in diagnosing and monitoring severe equine asthma.
Elevated cfDNA serves as a valuable biomarker of severe equine asthma, reflecting NET formation and ongoing neutrophil-driven inflammation.
These results encourage further research on NETs not only as biomarkers but also as potential targets for novel therapies to treat severe equine asthma.
Conclusion
Rapid, accurate field measurement of cfDNA by the Qubit 4 fluorometer provides a useful tool for distinguishing severe equine asthma from milder forms and healthy states.
This approach enhances understanding of disease mechanisms and supports improved diagnosis and management strategies in veterinary medicine.
Cite This Article
APA
Cooper BL, Hobbs KJ, Bayless R, Stinson-Miller A, Gruber E, Hepworth-Warren K, Lavoie JP, Sheats MK.
(2025).
A Portable Fluorometer Detects Significantly Elevated Cell-Free DNA in Tracheal Wash and Bronchoalveolar Lavage Fluid in Horses with Severe Asthma.
Animals (Basel), 15(23), 3483.
https://doi.org/10.3390/ani15233483
Ainsworth DM, Grünig G, Matychak MB, Young J, Wagner B, Erb HN, Antczak DF. Recurrent Airway Obstruction (RAO) in Horses Is Characterized by IFN-γ and IL-8 Production in Bronchoalveolar Lavage Cells. Vet. Immunol. Immunopathol. 2003;96:83–91.
Ng H, Havervall S, Rosell A, Aguilera K, Parv K, Von Meijenfeldt FA, Lisman T, MacKman N, Thålin C, Phillipson M. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arterioscler. Thromb. Vasc. Biol. 2021;41:988–994.
Letendre JA, Goggs R. Determining Prognosis in Canine Sepsis by Bedside Measurement of Cell-Free DNA and Nucleosomes. J. Vet. Emerg. Crit. Care. 2018;28:503–511.
Charoensappakit A, Sae-khow K, Rattanaliam P, Vutthikraivit N, Pecheenbuvan M, Udomkarnjananun S, Leelahavanichkul A. Cell-Free DNA as Diagnostic and Prognostic Biomarkers for Adult Sepsis: A Systematic Review and Meta-Analysis. Sci. Rep. 2023;13:19624.
Ware SA, Kliment CR, Giordano L, Redding KM, Rumsey WL, Bates S, Zhang Y, Sciurba FC, Nouraie SM, Kaufman BA. Cell-Free DNA Levels Associate with COPD Exacerbations and Mortality. Respir. Res. 2024;25:42.
Medina JE, Dracopoli NC, Bach PB, Lau A, Scharpf RB, Meijer GA, Andersen CL, Velculescu VE. Cell-Free DNA Approaches for Cancer Early Detection and Interception. J. Immunother. Cancer 2023;11:e006013.
Tullie S, Asiri A, Acharjee A, Moiemen NS, Lord JM, Harrison P, Hazeldine J. Day One Cell-Free DNA Levels as an Objective Prognostic Marker of Mortality in Major Burns Patients. Cells 2025;14:821.
Hampson P, Dinsdale RJ, Wearn CM, Bamford AL, Bishop JR, Hazeldine J, Moiemen NS, Harrison P, Lord JM. Neutrophil Dysfunction, Immature Granulocytes, and Cell-free DNA are Early Biomarkers of Sepsis in Burn-injured Patients: A Prospective Observational Cohort Study. Ann. Surg. 2017;265:1241–1249.
Neuberger EWI, Brahmer A, Ehlert T, Kluge K, Philippi KFA, Boedecker SC, Weinmann-Menke J, Simon P. Validating Quantitative PCR Assays for CfDNA Detection Without DNA Extraction in Exercising SLE Patients. Sci. Rep. 2021;11:13581.
Chen X, Chen C, Tu Z, Guo Z, Lu T, Li J, Wen Y, Chen D, Lei W, Wen W. Intranasal PAMAM-G3 Scavenges Cell-Free DNA Attenuating the Allergic Airway Inflammation. Cell Death Discov. 2024;10:213.
Hu Z, Chen H, Long Y, Li P, Gu Y. The Main Sources of Circulating Cell-Free DNA: Apoptosis, Necrosis and Active Secretion. Crit. Rev. Oncol./Hematol. 2021;157:103166.